Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

9.3%

4 terminated out of 43 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

44%

8 of 18 completed with results

Key Signals

8 with results82% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (15)
P 1 (7)
P 2 (10)
P 4 (1)

Trial Status

Completed18
Recruiting13
Terminated4
Unknown3
Active Not Recruiting3
Enrolling By Invitation1

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT00923221RecruitingPrimary

Collection of Blood From Patients With Prostate Cancer

NCT03354416Recruiting

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

NCT03181867Phase 2Active Not Recruiting

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

NCT04633252Phase 1RecruitingPrimary

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

NCT05361798Phase 2RecruitingPrimary

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

NCT07072728Phase 2Recruiting

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT00999960Not ApplicableTerminated

Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator

NCT03388619Phase 1CompletedPrimary

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

NCT04258813Not ApplicableActive Not Recruiting

Onco-primary Care Networking to Support TEAM-based Care

NCT06406803Not ApplicableRecruitingPrimary

The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients

NCT05252390Phase 1Terminated

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NCT04887935Phase 1Recruiting

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

NCT05600400Not ApplicableRecruiting

Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer

NCT04319783Phase 2Active Not Recruiting

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA

NCT05844761Not ApplicableEnrolling By Invitation

Real-time Motion Management During Prostate and Lung Radiotherapy

NCT06554587RecruitingPrimary

Investigation of Three Biomarkers for the Detection of Prostate Cancer

NCT01639859Not ApplicableCompletedPrimary

Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci

NCT02362464Phase 2Completed

Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

NCT05214937Not ApplicableRecruiting

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

NCT03579680Not ApplicableCompletedPrimary

De-implementation of Low Value Castration for Men With Prostate Cancer

Scroll to load more

Research Network

Activity Timeline